present oberon vcn.bc.ca Wow response injection doi improvement stroke etanercept group inc. etmd therapy size disability reperfusion salvage penumbra evidence penumbra site pathology activation activation necrosis factor neurotoxicity biologic antagonist activation brain injury administration etanercept treatment s disease delivery etanercept brain OBJECTIVE objective report response etanercept stroke cohort METHODS treatment rehabilitation clinic etanercept part clinic s practice medicine RESULTS hemiparesis addition stroke stroke artery brainstem medulla acute therapy dose etanercept stroke improvement administration response injection hemiparesis gait hand function perception speech cognition behaviour patient etanercept dose dose improvement CONCLUSIONS administration etanercept improvement dysfunction stroke pathophysiology intervention event etanercept dysfunction stroke PMID ********************************************** < @ leitl.org Message-ID eugen > -0700 > present > > > message heads-up Correction cryobc Yahoo group etc oberon vcn.bc.ca > > http leitl http http http mailing list lists.extropy.org http